Medication info
Genuwon Telmisartan Tablet 40 mg (Telmisartan)

Genuwon Telmisartan Tablet 40 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Genuwon Science Co., Ltd.
Appearance
White or off-white oblong tablet
Packaging
30 tablets/box (10 tablets/Alu-Alu x 3)
Approval status
Active

MFDS item code 201002450 · Approved 2010.03.31 · Insurance code 671702990

Summary

Main use
Treatment of essential hypertension; reduction and prevention of cardiovascular disease risk
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after initiation of treatment. This medicine has an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at a dose of 80 mg once daily with water; it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Genuwon Science Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; reduction and prevention of cardiovascular disease risk

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • high-risk diabetes with clinical evidence of end-organ damage
View approved original text

This drug is used for the treatment of essential hypertension. Additionally, in patients over 55 who are at high risk for cardiovascular disease and cannot use ACE inhibitors, it helps to reduce the risk of myocardial infarction, stroke, and death due to cardiovascular disease. It is particularly effective for high-risk diabetic patients with a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attack, or end-organ damage. This drug is used to manage hypertension and reduce the risk of major cardiovascular events.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after initiation of treatment. This medicine has an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at a dose of 80 mg once daily with water; it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This drug can cause serious harm to the fetus during pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. It should not be used in pregnant or potentially pregnant women, or in breastfeeding women. It is safer not to administer this drug in patients with severely impaired liver function or issues with bile excretion. Patients who have had allergic reactions to this drug or similar compounds in the past should avoid taking it. Caution is required when administering to patients with significantly reduced kidney function, particularly diabetic patients with low glomerular filtration rate and those taking certain medications with this drug. Elderly patients and those with elevated blood potassium levels should be closely monitored when taking this drug. Patients with heart or vascular diseases may experience side effects such as excessively low blood pressure, so caution is advised. Patients with gastrointestinal diseases should be cautious due to the risk of gastrointestinal bleeding. This drug may affect kidney function, so patients with kidney disease should undergo regular blood tests. Due to its strong blood pressure-lowering effect, if symptoms of low blood pressure appear, patients should lie down immediately and seek medical attention if necessary. This drug may interact with certain medications, so it is essential to consult with a doctor or pharmacist if taking other drugs. Caution is needed when driving or operating machinery due to the risk of dizziness or fainting. In case of overdose, symptoms such as decreased blood pressure, dizziness, and worsened kidney function may occur, requiring immediate visit to a medical facility. This drug is not recommended for children, as safety and efficacy have not been established. When taking, keep it out of reach of children and store it in the designated container.

Side effects

  • Upper respiratory tract infections
  • pharyngitis
  • sinusitis
  • urinary tract infections
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 124 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • liver function abnormalities
  • liver disorder
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug eruption
  • toxic skin eruption
  • eczema
  • urticaria
  • myalgia
  • low back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • increased liver enzymes
  • elevated serum creatine kinase
  • decreased hemoglobin
  • malaise
  • feeling of emptiness
  • cold sweat
  • tremor
  • decreased concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • syncope due to hypotension
  • loss of consciousness
  • jaundice
  • dyspnea
  • hypotension
  • laryngeal edema
  • fever
  • pneumonia
  • rhabdomyolysis
  • myalgia
  • elevated creatine kinase
  • increased serum myoglobin
  • increased urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • lack of effect
  • headache
  • dizziness
  • facial spasm
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • arrhythmia
  • malaise
  • edema
  • decreased libido
  • facial swelling
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • myalgia
  • dermatitis
  • dizziness
  • dyspepsia
  • cough
  • abdominal pain
  • loss of appetite
  • malaise
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea
  • hypotension
  • tachycardia
  • bradycardia
  • dizziness
  • acute renal failure

Not everyone experiences these, and they can vary from person to person.

Storage

This drug may be sensitive to air and moisture, so it must be stored in a sealed container. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness for a longer period.

Appearance and packaging

Appearance

White or off-white oblong tablet

Package unit

30 tablets/box (10 tablets/Alu-Alu x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.